Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Techne Corporation (NasdaqNM:TECH)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
Aug 14Earnings Announcement
Location
614 McKinley Place N.E.
Minneapolis, MN 55413
Phone: (612) 379-8854
Fax: (612) 379-6580
Email: info@rndsystems.com
Employees (last reported count): 387
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 600 SmallCap
Ownership
·Insider and 5%+ Owners: 27%
·Over the last 6 months:
 · one insider sell; 20.0K shares
  (0.2% of insider shares)
·Institutional: 75% (103% of float)
(344 institutions)
·Net Inst. Buying: 86.0K shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Techne Corporation is a holding company that has two wholly owned operating subsidiaries, Research and Diagnostic Systems, Inc. (R&D Systems) and R&D Systems Europe Ltd. (R&D Europe) R&D Systems is a specialty manufacturer of biological products. Its two major operating segments are hematology controls, which are used in hospital and clinical laboratories to check the accuracy of blood analysis instruments, biotechnology products including purified proteins (cytokines) and antibodies, which are sold exclusively to the research market, and assay kits, which are sold to the research and clinical diagnostic markets. R&D Europe distributes R&D Systems' biotechnology products in Europe. R&D Europe has a German sales subsidiary, R&D Systems GmbH. The Company also has a foreign sales corporation, Techne Export Inc.
More from Market Guide: Expanded Business Description

Financial Summary
Techne Corp., is engaged domestically in the development and manufacture of biotechnology products and hematology calibrators and controls which are distributed throughout Europe. For the nine months ended 3/31/01, net sales rose 11% to $84.7 million. Net income rose 36% to $24.7 million. Revenues reflect increased sales from the Biotechnology and Hematology divisions. Earnings also benefitted from favorable exchange effects and a one-time tax credit.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 30,705; after tax earnings were 9,395. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Thomas Oland, 59
Chairman, Pres, Treasurer
$230K$273K
Roger Lucas, Ph.D., 57
Vice Chairman
--  --  
Timothy Heaney, 54
VP, Sec., Gen. Counsel, Director
152K505K
Monica Tsang, Ph.D., 55
VP of Research
236K533K
Marcel Veronneau, 45
VP of Hematology Operations
148K642K
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:TECHAs of 31-Aug-2001
Price and Volume
52-Week Low
on 3-Jan-2001
$19.375
Recent Price$31.69 
52-Week High
on 23-Oct-2000
$66.438
Beta0.71 
Daily Volume (3-month avg)352.0K
Daily Volume (10-day avg)370.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-37.8%
52-Week Change
relative to S&P500
-16.5%
Share-Related Items
Market Capitalization$1.31B
Shares Outstanding41.4M
Float30.2M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 4-Dec-2000
Per-Share Data
Book Value (mrq*)$3.98 
Earnings (ttm)$0.80 
Earnings (mrq)$0.22 
Sales (ttm)$2.70 
Cash (mrq*)$2.12 
Valuation Ratios
Price/Book (mrq*)7.96 
Price/Earnings (ttm)39.71 
Price/Sales (ttm)11.73 
Income Statements
Sales (ttm)$115.4M
EBITDA (ttm*)$56.9M
Income available to common (ttm)$34.0M
Profitability
Profit Margin (ttm)29.5%
Operating Margin (ttm)41.5%
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)17.84%
Return on Equity (ttm)22.30%
Financial Strength
Current Ratio (mrq*)8.25 
Debt/Equity (mrq*)0.01 
Total Cash (mrq)$97.1M
Short Interest
As of 8-Aug-2001
Shares Short1.23M
Percent of Float4.1%
Shares Short
(Prior Month)
1.21M
Short Ratio4.50 
Daily Volume274.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.